| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |




*Molecular and Cellular Nephrology, Institute of Medical Sciences and Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa,
Department of Internal Medicine, University of Tokyo, Tokyo, and
Institute for Molecular and Cellular Biology, Osaka University, Suita, Osaka, Japan; and
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
Correspondence to Dr. Toshio Miyata, Molecular and Cellular Nephrology, Institute of Medical Sciences and Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan. Phone: +81-463-93-1936; Fax: +81-463-93-1938; E-mail: t-miyata{at}is.icc.u-tokai.ac.jp
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Using this novel methodology, we previously reported discovery of a new mesangium-predominant gene, megsin, which is a new member of the serine protease inhibitor (serpin) superfamily (2,3). Here, we cloned and characterized another novel gene, which was expressed ubiquitously but abundantly in mesangial cells.
Sequencing analysis of this gene demonstrated its structural homology with a regulatory subunit of protein serine/threonine phosphatase 4 (PP4R1) (4). Protein serine/threonine phosphatases (PP) play an important role in the control of most biologic processes by catalyzing the dephosphorylating reactions and serving as an off switch of cell signaling (5). The four major PP families that have been identified are PP1, PP2A, PP2B, and PP2C. This classification is based on their substrate selectivity, inhibitor sensitivity, and requirement for divalent cations (610).
PP4 is classified as a PP2A family member. The catalytic subunit of PP4 (PP4c) is 65% identical to the catalytic subunit of PP2A (PP2Ac). However, PP4c does not associate with the regulatory subunits of PP2A (11). Instead, PP4c seems to associate with distinct regulatory subunits (4).
The biologic function of PP4 has not been understood well. However, several lines of evidence suggest its potential involvement at centrosomes/spindle pole bodies for nucleation, growth, and/or stabilization of microtubules (12), which play an important role in each of the mitotic processes by forming the mitotic spindle and functioning in many of the subcellular movements.
In the present study, we determined the structure of the novel gene and investigated its biologic function and localization. Using anti-Thy1 glomerulonephritis, a model of mesangioproliferative glomerulonephritis of rats, we also investigated the temporal profile of its expression in association with mesangial proliferation.
| Materials and Methods |
|---|
|
|
|---|
To identify the 5' end of PP4Rmeg cDNA, we used the 5'-Full RACE Core Set (Takara, Tokyo, Japan). The reverse transcriptase (RT) reaction was performed with 1.0 µg of human mesangial cell polyA+ RNA with a gene-specific oligonucleotide. After degradation of the template mRNA with RNase H, the first-strand cDNA was circulated by T4 RNA ligase and an aliquot was used as a template for the first PCR amplification with gene-specific primers. The resulting PCR product was then used as a template for the second PCR amplification with nested gene-specific primers. The PCR products were cloned into the pCRII vector (Clontech, Palo Alto, CA), and DNA sequences were determined by dideoxy chain termination reaction using a DNA autosequencer.
Cloning of Rat PP4Rmeg
To determine the sequence of rat PP4Rmeg, we performed PCR with primers corresponding to highly homologous parts between human PP4Rmeg and mouse cDNA sequences that were obtained from the expression sequence tag database. Messenger RNA from cultured rat mesangial cells at passage of 10 to 20 with a Micro-FastTrack 2.0 mRNA Isolation Kit (Invitrogen, Groningen, the Netherlands) was reversed transcribed with Superscript II (Life Technologies) to generate template cDNA. The template was amplified in a DNA thermal cycler (Perkin Elmer Japan, Chiba, Japan) for 30 cycles using optimum conditions for each primer. To prevent misreading, we designed PCR primers so that each base could be determined in at least two different PCR products. We used a 5'RACE System, version 2.0 (Life Technologies) for the confirmation of the DNA sequence around the putative initiation codon. The PCR products were ligated into pGEM-T easy vector (Promega, Madison, WI), and DNA sequences of more than four clones were determined by dideoxy chain termination reaction with T7 and SP6 primers using a DNA autosequencer.
RT-PCR
Total RNA was isolated from cultured human mesangial cells (passage 10) and A431 cells (purchased from American Type Culture Collection, Manassas, VA) using ISOGEN (Nippon Gene, Tokyo, Japan) according to the manufacturers protocol. Approximately 2 µg of total RNA was reverse transcribed using an RNA-PCR kit (Takara). Ten microliters of cDNA was applied for PCR amplification.
PCR amplification was performed in a 25-µl reaction containing 2.5 U of ExTaq (Takara), 2.5 mM each of the four deoxynucleoside triphosphates, and 50 pmol of the KpnI-PP4Rs (5'-CCG GTA CCG GGC GAC CAC AAG ATG GCG GAC CT-3') and SacI-PP4Rs (5'-TCG AGC TCC CGC TCT CAC AGT TGG TTC TGA ATC-3') primers. Specimens were amplified in a DNA Thermal Cycler. Each cycle consisted of denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 30 s.
The PCR products were separated by electrophoresis in a 4% agarose gel and extracted using a QIAEX II kit (QIAGEN, Hilden, Germany). These products were ligated to pUC18 vector (Takara) after restriction enzyme digestion, and DNA sequences were confirmed by dideoxy chain termination reaction using a DNA autosequencer.
Production of PP4Rmeg Transfectants
Human PP4Rmeg cDNA was engineered with a c-Myc tag on the C-terminus as described below. The 5' terminal fragment of human PP4Rmeg (corresponding to 1 to 2210 bp) was obtained with digestion with EcoRI and HindIII. At the same time, the 3' terminal fragment was synthesized using a PCR-based method with the primers PP4Rmeg/2112 (5'-CGA GCT TGC AGT TAT TCT TGG AGA TCA ATT GAC AGC TGC-3') and BamHI-PP4RmegAS (5'-CGG GAT CCA CGT AGG TTG AGG ACG CTG TGC TCA TGG C-3'). These two fragments were confirmed by sequence analysis, followed by simultaneous ligation into pcDNA 3.1/myc-His B vector (Invitrogen) with a Takara Ligation Kit Version 2.0.
The pcDNA 3.1/myc-His B vector containing PP4Rmeg was transfected into COS-7 cells cultured in Dulbeccos modified Eagles medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% fetal bovine serum. Transfections were performed using 5 µg of PP4Rmeg expression vector and 2.5 µl of LIPOFECTAMINE Reagent (Life Technologies) according to the manufacturers protocol. Sixty hours posttransfection, cells were dislodged by scraping in 1 ml of phosphate-buffered saline and stored at -80°C until use. Approximately 8 x 105 cells were lysed in 400 µl of Buffer A (20 mM Tris-HCl [pH 7.5], 100 mM NaCl, 0.5% Triton X-100, 1 mM ethylenediaminetetraacetate, 1 mM ethyleneglycol-bis(ß-aminoethyl ether)-N,N'-tetraacetic acid, 1 mM dithiothreitol, and a cocktail of protease inhibitors, which included leupeptin, pepstatin, aprotinin, benzamidine, and soybean trypsin inhibitors) by repetitive passage (8 to 10 times) through a 22-gauge needle. The cell lysates were clarified by centrifugation for 10 min at 4°C, and the supernatant was taken as cell lysates and solubilized in sodium dodecyl sulfate (SDS) sample buffer, which represented starting material.
Immunoprecipitation
The ability of recombinant PP4Rmeg (myc-PP4Rmeg) to bind PP4c was assessed by immunoprecipitation using specific antibodies. Cell lysates (350 µg of protein) were incubated with 2 µl of c-Myc antibody (Clontech) overnight while rotating at 4°C. Immune complexes were isolated by adding 40 µl of a 50% slurry of Buffer A-washed GammaBind Plus Sepharose (Amersham Pharmacia Biotech) resin. The protein-antibody-beads complexes were pelleted by centrifugation, and the supernatant was taken, an aliquot of which was solubilized in SDS sample buffer, which represented unbound proteins. After the beads were washed six times with Buffer A, bound proteins were eluted with 30 µl of 2x SDS sample buffer and then with 25 µl of 1x SDS sample buffer, which represented immunoprecipitated proteins. Samples were analyzed by immunoblot analysis using an affinity-purified antibody raised against the amino acid residues 56 to 69 (ASENIFNRQMVARS) in PP4R1 (4) and an affinity-purified antibody directed against the C terminus of PP4c (4).
Immunoblot Analysis
Approximately 20 µl of starting material, unbound protein, and immunoprecipitated protein were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. Proteins were transferred to nylon-reinforced nitrocellulose in 10 mM 3-(cyclohexylamine)propanesulfonic acid buffer (pH 11.0) containing 10% methanol. The blots were incubated with affinity-purified antibody raised against the amino acid residues 56 to 69 (ASENIFNRQMVARS) in PP4R1 (4) and an affinity-purified antibody directed against the C terminus of PP4c (4), followed by incubation with goat anti-rabbit IgG-alkaline phosphatase conjugate. Immunocomplexes were visualized with 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium as substrates for alkaline phosphatase.
Northern Blot Analysis
The expression of PP4 regulatory subunits (PP4Rs) mRNA was assessed in various human primary cultured cells and tissues, as well as in glomeruli isolated from anti-Thy1 glomerulonephritis rats. Cultured human mesangial cells, dermal fibroblasts, proximal tubule epithelial cells, umbilical vein endothelial cells, and aortic smooth muscle cells were purchased from Takara, and their mRNA were isolated at passage 5 to 15 using a Micro-FastTrack 2.0 Kit (Invitrogen). A human multiple tissue Northern blot containing polyA+ RNA from heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas was purchased from Clontech. Total RNA was isolated from glomeruli of anti-Thy1 glomerulonephritis rats described below, using an ISOGEN kit (Nippon Gene).
PolyA+ RNA from cultured human cells (2 µg) or total RNA from anti-Thy1 glomerulonephritis glomeruli (4 µg) were electrophoretically separated in 1% agarose gels containing 2.2 mol/L formaldehyde, followed by capillary transfer to nitrocellulose membrane GeneScreenPlus (NEN, Boston, MA). The membrane was prehybridized in Quikhyb Hybridization solution (Stratagene, La Jolla, CA) at 68°C for 1 h, followed by hybridization in Quikhyb Hybridization solution containing labeled probe and salmon sperm DNA at 68°C for 2 h. After hybridization, membranes were washed with 0.2x SSC/0.1% SDS at 60°C.
As a probe for human PP4 regulatory subunits (PP4Rs), we used a 625-bp-long cDNA fragment cut with PvuII (corresponding to 2734 to 3359 bp). As a probe for rat PP4Rs, we used a 1141-bp-long cDNA fragment (corresponding to 894 to 2034 bp). These DNA fragments were radiolabeled using Random Primer DNA Labeling Kit (Takara) and purified with ProbeQuant G-50 Micro columns (Amersham Pharmacia Biotech).
Quantification of the PP4R mRNA signals was obtained by densitometry using National Institutes of Health image software (version 1.62; Bethesda, MD). The intensities of the signals were normalized using ß-actin mRNA or 28S ribosomal RNA as loading controls.
In Situ Hybridization
In situ hybridization was performed as described previously (13). Briefly, fresh kidney biopsy tissues were embedded in OCT compound, frozen quickly, and stored at -80°C until use. Sections of tissues were cut 4 µm thick and fixed in 4% paraformaldehyde in phosphate-buffered saline deproteinized by HCl and digested with proteinase K (Sigma Chemical, St. Louis, MO). The specimens were incubated in a prehybridization buffer, drained, and hybridized overnight with digoxigenin (DIG)-labeled oligonucleotide probe in the prehybridization buffer. As a probe, we used 34-bp-long synthesized oligonucleotide corresponding to nucleotides 2879 to 2912. After hybridization, the DIG-labeled probe was visualized by immunohistochemical staining using a mouse monoclonal anti-DIG antibody (Boehringer Mannheim, Mannheim, Germany), horseradish peroxidase-conjugated rabbit anti-mouse antibody (DAKO, Kyoto, Japan), and horseradish peroxidase-conjugated swine anti-rabbit antibody (DAKO). Color was developed with diaminobenzidine tetrahydrochloride in 0.05 M Tris-HCl (pH 7.6) and 0.03% H2O2. Sections were briefly counterstained with hematoxylin, rinsed, dehydrated, cleared in xylene, and mounted.
Anti-Thy1 Glomerulonephritis Rat Experiment
Anti-Thy1 glomerulonephritis was induced in 21 male Wistar rats (Nippon Clea, Tokyo, Japan) that weighed approximately 200 g using a hybridoma line producing anti-rat Thy1.1 antibody from European Collection of Animal Cell Culture (Sulisbury, UK); purification of anti-Thy1.1 monoclonal antibody was performed as reported (14). To induce anti-Thy1 glomerulonephritis, purified anti-rat Thy1.1 antibody (2.4 mg/kg body wt) was injected intravenously. Three rats were killed at each time point (days 2, 4, 7, 14, and 28) along with three control rats. Rat kidneys were removed, followed by glomerular isolation by standard sieving method (15) and preparation of total RNA for Northern blot analysis. A portion of tissue was fixed in methyl-Carnoys solution, embedded in paraffin, sectioned 4 µm thick, and stained with the periodic acid-Schiff reagent and counterstained with hematoxylin. Immunohistochemical staining with mouse antiproliferating cell nuclear antigen (PCNA) monoclonal antibody PC10 (DAKO) was performed as described previously (16). The number of intraglomerular cells and PCNA-positive glomerular cells on 20 randomly selected glomeruli was determined. Glomerular cross-sections containing only a minor portion of the glomerular tuft (<20 discrete capillary segments per cross-section) were not used.
| Results |
|---|
|
|
|---|
Using PCR techniques, we isolated a full-length cDNA. Nucleotide sequencing analysis of this clone revealed an open reading frame of 2850 nucleotides coding for a predicted protein of 950 amino acids (Figure 1). The sequence around the initiation codon (AAGATGG) was consistent with Kozaks consensus sequence (A/GCCATGG). Stop codons in all three reading frames were identified upstream of the initiation codon.
|
We confirmed by RT-PCR that cultured human mesangial cells and the A431 cell line contained both PP4Rmeg and PP4R1 transcripts (Figure 2). Nucleotide sequence analyses of the 275- and 326-bp PCR products established that they were PP4R1 and PP4Rmeg, respectively.
|
To investigate whether PP4Rmeg was conserved in other species, we cloned a partial cDNA of the rat homologue of PP4Rmeg from cultured rat mesangial cells. The determined DNA sequences covered the putative open reading frame, and the 18 amino acids that we found in the N-terminus of human PP4Rmeg also existed in rat PP4Rmeg. The DNA sequence of this region was almost identical with that of human PP4Rmeg. At the amino acid level, rat PP4Rmeg was 86.3% identical to human PP4Rmeg (Figure 1). The regions of the heat repeat sequences were highly conserved in rat PP4Rmeg.
Binding of PP4Rmeg to PP4c
The high homology of PP4Rmeg with the recently reported regulatory subunit of PP4, PP4R1, suggested that PP4Rmeg might bind to PP4c. To test this, we transfected COS-7 cells with Myc-PP4Rmeg, and recombinant Myc-PP4Rmeg (M.W.: 135 kD, Figure 3A) was immunoprecipitated from the cell lysates using anti-Myc antibody. The immune complexes were analyzed for PP4c by immunoblotting. As shown in Figure 3B, PP4c co-precipitated with recombinant Myc-PP4Rmeg from cell lysates of Myc-PP4Rmeg transfectants. No PP4c was detected in the anti-Myc immune complexes from lysates of mock-transfected cells. These results indicate that recombinant PP4Rmeg bound to endogenous PP4c, suggesting that PP4Rmeg functions as a regulatory subunit of PP4.
|
A single transcript of 4.5 kb was detected in cultured mesangial cells (Figure 4A). PP4Rs were also detected in other human cells, e.g., dermal fibroblasts, tubular epithelial cells, umbilical vein endothelial cells, and aortic smooth muscle cells, but were most highly expressed in mesangial cells. The PP4R mRNA were ubiquitously expressed in the various organs and most highly expressed in heart and placenta (Figure 4B).
|
|
|
|
| Discussion |
|---|
|
|
|---|
Structural and functional analyses of PP4Rmeg revealed that it was closely related to the recently reported novel regulatory subunit of PP4, PP4R1 (4). The amino acid sequences of PP4Rmeg and PP4R1 were almost identical except that serine-18 in PP4R1 was replaced by 18 amino acids (FGVDDYSSESDVIIIPSA) in PP4Rmeg. Despite the additional amino acid insertion at the N-terminus, PP4Rmeg seems to be biologically similar to PP4R1. Our immunoprecipitation studies demonstrated that recombinant PP4Rmeg can associate with endogenous PP4c in cell lysates, supporting the idea that PP4Rmeg functions as a regulatory subunit of PP4. In good agreement with this, Kloeker and Wadzinski (4) previously demonstrated that PP4R1 migrated as a doublet on SDS-PAGE and exhibited a fairly broad peak (approximately 105 kD) by mass spectrometry, suggesting the possibility of the isoform(s) of PP4R1.
According to the genomic information in the GenBank database, PP4Rmeg seems to be localized on chromosome 18. The PP4Rmeg-specific sequence, which is 51 bp long, is located on the 5' part of the third exon consisting of 136-bp nucleotides. The sequences of the 3' end of intron 2 and the PP4Rmeg-specific part are consistent with consensus sequences for donor sites of alternative splicing. PP4Rmeg and PP4R1 therefore may be splicing variants of a common gene. Both PP4Rmeg and PP4R1 are expressed in human mesangial cells and A431 cells. However, the difference of function and enzymatic activity between these two molecules remains to be determined.
In the present study, we showed ubiquitous expression of PP4 regulatory subunits in various human organs. This result is in accordance with the fact that PP4 is the protein with biologically basic functions. Although our Northern blot analysis demonstrated that PP4Rs were expressed to some degree in most, if not all, cultured cells examined thus far, we observed higher expression of PP4Rs mRNA in cultured mesangial cells. The result of the present in situ hybridization studies also supported high expression of PP4Rs in glomerular cells in vivo.
Our immunoprecipitation studies demonstrating the association of PP4Rmeg with PP4c suggest that a functional role for PP4Rmeg is similar to PP4R1. This may give us a clue to its biologic functions. PP4 has been localize at centrosomes/spindle pole bodies in human and Drosophila cells (11). The Drosophila melanogaster strain containing a mutated PP4c gene exhibits a semilethal phenotype with abnormal mitotic spindle microtubules (12). Most cell-cycle-dependent regulation of microtubule assembly occurs through changes in microtubule-associated protein phosphorylation state (reviewed in reference (20). Thus, PP4 may regulate cell mitosis by locally dephosphorylating centrosomal or microtubule-associated proteins, thereby regulating microtubule growth initiation or stability. We speculate that PP4Rmeg controls cell mitosis by regulating the activities of key phosphoproteins. Although some proteins, including
-tubulin and CP60, have been considered to be potential candidates (12), the in vivo substrates have not identified. To uncover the mechanism of cytokinesis, it will be important to identify the substrates and to determine the precise function of PP4 in cell mitosis.
In this context, of particular interest is the potential involvement of PP4Rmeg in the regulation of mesangial cell division and proliferation. This stimulated us to investigate expression profiles of PP4Rmeg in mesangial injury and repair. Our present results using anti-Thy1 glomerulonephritis rats suggest a link between the upregulation of PP4Rmeg expression and mesangial proliferation. After intravenous administration of anti-Thy1 antibody, the number of endogenous glomerular cells decreases as a result of mesangiolysis. This phase is transient and followed by the recovery phase with mesangial proliferation (19). Our studies demonstrate that the upregulation of PP4Rmeg mRNA expression preceded mesangial proliferation. These results are consistent with our hypothesis that PP4Rmeg serves as a regulator of cell division in glomeruli. However, functional studies are required to conclude that PP4Rmeg plays a role in this process.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. I. Chen, S. Tisayakorn, C. Jorgensen, L. M. D'Ambrosio, M. Goudreault, and A.-C. Gingras PP4R4/KIAA1622 Forms a Novel Stable Cytosolic Complex with Phosphoprotein Phosphatase 4 J. Biol. Chem., October 24, 2008; 283(43): 29273 - 29284. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, Y. Ozawa, H. Lee, Y.-D. Wen, T.-H. Tan, B. E. Wadzinski, and E. Seto Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4 Genes & Dev., April 1, 2005; 19(7): 827 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhou, J. S. Boomer, and T.-H. Tan Protein Phosphatase 4 Is a Positive Regulator of Hematopoietic Progenitor Kinase 1 J. Biol. Chem., November 19, 2004; 279(47): 49551 - 49561. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Mihindukulasuriya, G. Zhou, J. Qin, and T.-H. Tan Protein Phosphatase 4 Interacts with and Down-regulates Insulin Receptor Substrate 4 following Tumor Necrosis Factor-{alpha} Stimulation J. Biol. Chem., November 5, 2004; 279(45): 46588 - 46594. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wells, L. K. Kreppel, F. I. Comer, B. E. Wadzinski, and G. W. Hart O-GlcNAc Transferase Is in a Functional Complex with Protein Phosphatase 1 Catalytic Subunits J. Biol. Chem., September 10, 2004; 279(37): 38466 - 38470. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |